While studies have probed the involvement of ANRIL in cardiovascular disease susceptibility and phenotypes17,20,21, less is known about how ANRIL plays a role in T2D, despite multiple strongly validated T2D risk polymorphisms within or near this gene locus13. Here, CDKN2B-AS1 is linked to cardiovascular disorder.